Skip to contentViswanathan Ravi — TESARO, Inc. insider: 267 transactions · InsiderLensViswanathan Ravi
- 10% owner at Clovis Oncology, Inc. · on record since Nov 22, 2011
- 10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 31, 2016
- 10% owner at METAL MANAGEMENT INC · on record since Mar 28, 2012
- 10% owner at TESARO, Inc. · on record since Jun 27, 2012
- 10% owner at Workday, Inc. · on record since Oct 18, 2012
- 10% owner at Epizyme, Inc. · on record since May 30, 2013
- 10% owner at INTERLEUKIN GENETICS INC · on record since May 23, 2013
- 10% owner at Omthera Pharmaceuticals, Inc. · on record since Apr 17, 2013
- Director at Omthera Pharmaceuticals, Inc. · on record since Jul 18, 2013
- 10% owner at TCW CONVERTIBLE SECURITIES FUND INC · on record since Aug 14, 2013
- 10% owner at Care.com Inc · on record since Jan 29, 2014
- 10% owner at HIVE Digital Technologies Ltd. · on record since Mar 27, 2014
- 10% owner at GLYCOMIMETICS INC · on record since Jan 15, 2014
- 10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
- 10% owner at Roka BioScience, Inc. · on record since Jul 22, 2014
- 10% owner at Journey Medical Corp · on record since Oct 8, 2014
- 10% owner at SeaCube Container Leasing Ltd. · on record since Jan 29, 2015
- 10% owner at Tracon Pharmaceuticals, Inc. · on record since Jan 29, 2015
- 10% owner at CHAMPIONS SPORTS INC · on record since Mar 24, 2015
- 10% owner at NUVELO INC · on record since Jun 17, 2015
- 10% owner at ARDELYX, INC. · on record since Jun 9, 2015
- 10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
- 10% owner at ADVANCE TECHNOLOGIES INC · on record since Oct 20, 2015
- 10% owner at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
- 10% owner at AVEO PHARMACEUTICALS INC · on record since May 17, 2016
- 10% owner at Achaogen Inc · on record since Jun 7, 2016
- 10% owner at MULESOFT, INC · on record since Mar 22, 2017
- 10% owner at CASCADE CORP · on record since Feb 1, 2017
- 10% owner at APPIAN CORP · on record since May 31, 2017
- 10% owner at Mersana Therapeutics, Inc. · on record since Jun 27, 2017
- 10% owner at Regulus Therapeutics Inc. · on record since Jul 31, 2017
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 10, 2017
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jan 23, 2018
- 10% owner at Strongbridge Biopharma plc · on record since Jan 9, 2018
- 10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018
- 10% owner at PhaseBio Pharmaceuticals Inc · on record since Oct 24, 2018
- 10% owner at TAPIMMUNE INC · on record since Oct 18, 2018
- 10% owner at Elastic N.V. · on record since Oct 10, 2018
- 10% owner at Duolingo, Inc. · on record since Jul 27, 2021
Insider trading activity of Viswanathan Ravi
- Transactions on record
- 267
- since Nov 22, 2011
- Open-market buys
- 68
- $268.2M
- Open-market sells
- 12
- $134.6M
- Companies traded
- 31
- last filing Jun 28, 2022
Figures computed from official regulatory filings — methodology.
Companies where Viswanathan Ravi has traded
- Duolingo, Inc.12 tx · Jun 28, 2022
- Elastic N.V.4 tx · Oct 10, 2018
- Adaptimmune Therapeutics PLC8 tx · $49.1M · Sep 10, 2018
- AVEO PHARMACEUTICALS INC14 tx · $8.2M · Aug 22, 2018
- ARDELYX, INC.6 tx · $26.7M · May 30, 2018
- MULESOFT, INC26 tx · May 9, 2018
- Surface Oncology, Inc.3 tx · $2M · Apr 23, 2018
- Tracon Pharmaceuticals, Inc.6 tx · $12M · Mar 27, 2018
- CASCADE CORP3 tx · $6M · Mar 13, 2018
- TESARO, Inc.
Track record of Viswanathan Ravi
Statistical track record
Free- Open-market buys
- 74
- Last buy
- Sep 7, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Viswanathan Ravi
Co-insiders of Viswanathan Ravi
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
32 tx · $73.4M · Mar 6, 2018
KERINS PATRICK JAdaptimmune Therapeutics PLC +14
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 28, 2022 | Other | 5,733 | 0.00 USD | $0 | SEC |
| Jun 28, 2022 | Other | -5,733 | 0.00 USD | $0 | SEC |
| Jun 28, 2022 | Other | -500,000 | 0.00 USD | $0 | SEC |
| Jun 28, 2022 | Other | 1,097 | 0.00 USD | $0 | SEC |
| Mar 25, 2022 | Other | -1,000,000 | 0.00 USD | $0 | SEC |
| Mar 25, 2022 | Other | 2,194 | 0.00 USD | $0 | SEC |
| Mar 25, 2022 | Other | -11,467 | 0.00 USD | $0 | SEC |
| Mar 25, 2022 | Other | 11,467 | 0.00 USD | $0 | SEC |
| Feb 16, 2022 | Other | -500,000 | 0.00 USD | $0 | SEC |
| Feb 16, 2022 | Other | 5,732 | 0.00 USD | $0 | SEC |
| Feb 16, 2022 | Other | -5,732 | 0.00 USD | $0 | SEC |
| Feb 16, 2022 | Other | 1,096 | 0.00 USD | $0 | SEC |
| Oct 10, 2018 | Other | 4,155,995 | — | — | SEC |
| Oct 10, 2018 | OtherD | -1,528,117 | — | — | SEC |
| Oct 10, 2018 | Other | 1,528,117 | — | — | SEC |
| Oct 10, 2018 | OtherD | -4,155,995 | — | — | SEC |
| Sep 10, 2018 | Buy | 12,000,000 | 1.67 USD | $20M | SEC |
| Sep 10, 2018 | Buy | 3,000,000 | 1.67 USD | $5M | SEC |
| Aug 22, 2018 | Buy | 663,716 | 2.26 USD | $1.5M | SEC |
| Jul 20, 2018 | Buy | 200,000 | 1.95 USD | $390K | SEC |
| Jul 20, 2018 | Buy | 50,600 | 2.00 USD | $101.2K | SEC |
| Jun 28, 2018 | Buy | 187,130 | 2.10 USD | $393K | SEC |
| Jun 28, 2018 | Buy | 5,295 | 2.15 USD | $11.4K | SEC |
| May 30, 2018 | Award | 416,667 | 4.00 USD | $1.7M | SEC |
| May 30, 2018 | Buy | 275 | 2.15 USD | $591.3 | SEC |